CLL-SLL/MTT Episode 2 of 3 - Moving Towards Fixed-Duration Therapy in CLL and SLL

The emergence of fixed-duration therapy, which combines two or more drugs within a set timeframe, has shown promise for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). However, it leads to many clinical questions regarding establishing an optimal combinational therapy and sequence to best fit the needs of the patient. Join us for the second episode of the 3-part educational series First-line Treatment of CLL/SLL: New Data and Practical Strategies for Practice Improvement as our experts and special guests discuss the implications of the new data in fixed-duration therapy, as well as strategies to promote inclusive clinical trial participation.